IDO1 and neoplasm: Glioblastoma immunosuppressive TME is driven by tumor-intrinsic factors and brain (host) tissue responses to tumor antigens, such as overexpression of the indoleamine 2,3-dioxygenase (IDO) enzyme [54,55] and oncogene transforming growth factor-beta (TGF-β), respectively.